AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR-23.6%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-23.6%/yr
vs +50.6%/yr prior
Acceleration
-74.2pp
Decelerating
Percentile
P64
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.62% |
| Q3 2025 | -30.00% |
| Q2 2025 | 2.94% |
| Q1 2025 | -3.57% |
| Q4 2024 | 1.69% |
| Q3 2024 | 2.04% |
| Q2 2024 | 8.65% |
| Q1 2024 | -1.54% |
| Q4 2023 | 5.49% |
| Q3 2023 | 7.76% |
| Q2 2023 | 15.73% |
| Q1 2023 | -8.74% |
| Q4 2022 | 10.35% |
| Q3 2022 | -5.31% |
| Q2 2022 | 12.56% |
| Q1 2022 | -8.67% |
| Q4 2021 | -5.19% |
| Q3 2021 | 3.01% |
| Q2 2021 | 0.87% |
| Q1 2021 | -12.80% |
| Q4 2020 | -4.41% |
| Q3 2020 | 12.80% |
| Q2 2020 | 4.63% |
| Q1 2020 | 0.95% |
| Q4 2019 | 3.03% |
| Q3 2019 | 2.74% |
| Q2 2019 | 21.89% |
| Q1 2019 | -10.79% |
| Q4 2018 | 6.82% |
| Q3 2018 | 15.60% |
| Q2 2018 | 11.08% |
| Q1 2018 | -17.10% |
| Q4 2017 | -5.00% |
| Q3 2017 | 21.57% |
| Q2 2017 | 12.43% |
| Q1 2017 | -10.79% |
| Q4 2016 | 2.37% |
| Q3 2016 | 2.71% |
| Q2 2016 | 2.93% |
| Q1 2016 | 4.51% |